REFERENCES

• KesslerRC.BerglundP.DemlerO.et al.The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).JAMA.20032893095310512813115
   PubMed Web of Science ®Google Scholar
• MurrayCJL.LopezAD.The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, Mass: Harvard School of Public Health on behalf of the World Health Organization and the World Bank, Harvard University Press;1996
   Google Scholar
• CassanoGB.RucciP.FrankE.et al.The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach.Am J Psychiatry.20041611264126915229060
   PubMed Web of Science ®Google Scholar
• FrankE.CyranowskiJM.RucciP.et al.Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar l disorder.Arch Gen Psychiatry.20025990591112365877
   PubMed Web of Science ®Google Scholar
• KupferDJ.FirstMB.RegierDA.edsA Research Agenda for DSM-V. Washington, DC: American Psychiatric Association;2002
   Google Scholar
• InskipHM.HarrisEC.BarracloughB.Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia.Br J Psychiatry.199817235379534829
   PubMed Web of Science ®Google Scholar
• RichelsonE.The clinical relevance of antidepressant interactions with neurotransmitter transporters and receptors.Psychopharmacol Bull.20023613314912858153
   PubMedGoogle Scholar
• TammingaCA.NemeroffCB.BlakelyRD.et al.Developing novel treatments for mood disorders: accelerating discovery.Biol Psychiatry.20025258960912361670
   PubMed Web of Science ®Google Scholar
• ManjiHK.DrevetsWC.CharneyDS.The cellular neurobiology of depression.Nat Med.2001754154711329053
   PubMed Web of Science ®Google Scholar
• McEwenB.Mood disorders and allostatic load.Biol Psychiatry.20035420020712893096
   PubMed Web of Science ®Google Scholar
• WhooleyMA.SimonGE.Managing depression in medical outpatients.N Engl J Med.20003431942195011136266
   PubMed Web of Science ®Google Scholar
• BeckA.RushA.ShawB.EmeryG.Cognitive Therapy of Depression. New York, NY: Guilford Press;1979
   Google Scholar
• KlermanMM.WeissmanBJ.RounsavilleBJ.ChevronES.edsInterpersonal Psychotherapy of Depression. New York, NY: Basic Books;1984
   Google Scholar
• WeissmanMM.MarkowitzJC.KlermanGL.edsComprehensive Guide to Interpersonal Psychotherapy. New York, NY: Basic Books;2000
   Google Scholar
• GoldsmithSK.PellmarTC.KleinmanAM.BunneyWE.edsInstitute of Medicine, National Academy of Sciences: Reducing Suicide, a National Imperative. Washington, DC: The National Academies Press;2002
   Google Scholar
• SzantoK.MulsantBH.HouckP.DewMA.ReynoldsCF.Occurrence and course of suicidally during short-term treatment of late-life depression.Arch Gen Psychiatry.20036061061712796224
   PubMed Web of Science ®Google Scholar
• LinEH.KatonWJ.VonKorffM.et al.Relapse of depression in primary care: rate and clinical predictors.Arch Fam Med.199874434499755737
   PubMedGoogle Scholar
• RushAJ.CrismonML.KashnerTM.et al.Texas Medication Algorithm Project, Phase 3 (TMAP-3): rationale and study design.J Clin Psychiatry.20036435736912716235
   PubMed Web of Science ®Google Scholar
• JuddLL.AkiskalHS.MaserJD.et al.Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapidrelapse. J Affect Disord.19985097108
   PubMed Web of Science ®Google Scholar
• SimonGE.RevickiD.HeiligensteinJ.et al.Recovery from depression, work productivity, and health care costs among primary care patients.Gen Hosp Psychiatry.20002215316210880708
   PubMed Web of Science ®Google Scholar
• PrïenRF.KupferDJ.ManskyPA.et al.Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: a report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination.Arch Gen Psychiatry.198441109611046437366
   PubMed Web of Science ®Google Scholar
• FrankE.KupferDJ.PerelJM.et al.Three-year outcomes for maintenance therapies in recurrent depression.Arch Gen Psychiatry.199047109310992244793
   PubMed Web of Science ®Google Scholar
• ReynoldsCF.FrankE.PerelJM.et al.Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.JAMA199928139459892449
   PubMed Web of Science ®Google Scholar
• QuitkinFM.StewartJW.McGrathPJ.et al.Columbia atypical depression: a subgroup of dépressives with better response to MAOI than to tricyclic antidepressants or placebo.Br J Psychiatry.19931633034
   Web of Science ®Google Scholar
• ThaseME.TrivediMH.RushAJ.MAOI in the contemporary treatment of depression.Neuropsychopharmacology.1995121852197612154
   PubMed Web of Science ®Google Scholar
• WilliamsJW Jr.MulrowCD.ChiquetteE.HitchcockP.AguilarC.CornellJ.A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.Ann Intern Med.200013274375610787370
   PubMed Web of Science ®Google Scholar
• MacGillïvrayS.ArrollB.HatcherS.et al.Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.BMJ.20033261014101912742924
   PubMed Web of Science ®Google Scholar
• ThaseME.EntsuahAR.RudolphRL.Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.Br J Psychiatry.20017823424111230034
   PubMedGoogle Scholar
• SmithD.DempsterC.GlanvilleJ.FreemantleN.AndersonI.Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.Br J Psychiatry.200218039640411983635
   PubMed Web of Science ®Google Scholar
• WallaceAE.KofoedLL.WestAN.Double-blind placebo-controlled trial of methylphenidate in older, depressed, medically ill patients.Am J Psychiatry.19951529299317755127
   PubMed Web of Science ®Google Scholar
• LecrubïerY.ClercG.DidïR.KïeserM.Efficacy of St John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.Am J Psychiatry.20021591361136612153829
   PubMed Web of Science ®Google Scholar
• LindeK.RamirezG.MulrowDC.PaulsA.WeidenhammerW.MelchartD.St John's wort for depression: an overview and meta-analysis of randomised clinical trials.BMJ.19963132532588704532
   PubMed Web of Science ®Google Scholar
• Hypericum Depression Trial Study Group: Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trialJAMA20022871807181411939866
   PubMed Web of Science ®Google Scholar
• KupferDJ.FrankE.Placebo in clinical trials for depression: complexity and necessity (Editorial).JAMA.20022871853185411939872
   PubMed Web of Science ®Google Scholar
• SheltonRC.KellerMB.GelenbergA.et al.Effectiveness of St John's wort in major depression: a randomized controlled trial.JAMA.20012851978198611308434
   PubMed Web of Science ®Google Scholar
• HaddadPM.Antidepressant discontinuation syndromes. Clinical relevance, prevention and management.Drug Saf.20012418319711347722
   PubMed Web of Science ®Google Scholar
• LiuB.MittmanN.KnowlesS.et al.Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.Can Med Assoc J.19961555195278804257
   PubMed Web of Science ®Google Scholar
• OlverJ.BurrowsG.NormanT.Third-generation antidepressants: do they offer advantages over the SSRI?CNS Drugs.20011594195411735614
   PubMed Web of Science ®Google Scholar
• GillHS.DeVaneLC.RischCS.Extrapyramidal symptoms associate with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses.J Clin Psychopharmacol.1997173773899315989
   PubMed Web of Science ®Google Scholar
• RosenRC.LaneRM.MenzaM.Effects of SSRI on sexual function: a critical review.J Clin Psychopharmacol.19991967859934946
   PubMed Web of Science ®Google Scholar
• PerettiS.JudgeR.HindmarchI.Safety and tolerability considerations: tricyclic antidepressants vs selective serotonin reuptake inhibitors.Acta Psychiatr Scand Suppl.2000403172511019931
   PubMedGoogle Scholar
• WaldingerMD.HengeveldMW.ZwïndermanAH.et al.Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.J Clin Psychopharmacol.1998182742819690692
   PubMed Web of Science ®Google Scholar
• RosenbaumJF.FavaM.HoogSL.et al.Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.Biol Psychiatry.19984477879646889
   PubMed Web of Science ®Google Scholar
• HausteinK-O.HaffnerS.WoodcockBG.A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients.IntJ Clin Pharmacol Ther.20024040441812358157
   PubMed Web of Science ®Google Scholar
• BrentDA.BirmaherB.Adolescent depression.N Engl J Med.200234766767112200555
   PubMed Web of Science ®Google Scholar
• OxmanTE.BarrettJE.BarrettJ.GerberP.Symptomatology of late life minor depression among primary-care patients.Psychosomatics.1990311741802330398
   PubMed Web of Science ®Google Scholar
• LynessJM.CaineED.KingDA.CoxC.YoedionoZ.Psychiatric disorders in older primary care patients.J Gen Intern Med.19991424925410203638
   PubMed Web of Science ®Google Scholar
• SchulbergHC.KatonWJ.SimonGE.RushAJ.Best clinical practice: guidelines for managing major depression in primary medical care.J Clin Psychiatry.199960(suppl 7)S19S26
   PubMed Web of Science ®Google Scholar
• EmslieGJ.RushAJ.WeinbergWA.et al.A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.Arch Gen Psychiatry.199754103110379366660
   PubMed Web of Science ®Google Scholar
• KellerM.RyanND.StroberM.et al.Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled study.J Am Acad Child Adolesc Psychiatry.20014076277211437014
   PubMed Web of Science ®Google Scholar
• WagnerKD.RobbAS.FindlingRL.JinJ.GutierrezMM.HeydornWE.A randomized, placebo-controlled trial of citalpram for the treatment of major depression in children and adolescents.Am J Psychiatry.20041611079108315169696
   PubMed Web of Science ®Google Scholar
• AxelsonDA.PerelJM.BirmaherB.et al.Sertraline pharmacokinetics and dynamics inadolescents. J Am Acad Child Adolesc Psychiatry.20024110371044
   PubMed Web of Science ®Google Scholar
• Treatment for Adolescents with Depression Study (TADS) Team Treatment for Adolescents with Depression Study (TADS) randomized controlled trials: fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression.JAMA.200429280782015315995
   PubMed Web of Science ®Google Scholar
• AlexopoulosGS.KatzI.ReynoldsCF.CarpenterD.DochertyJP.RossRW.Pharmacotherapy of depressive disorders in older patients: a summary of the expert consensus guidelines.J Psychiatr Prac.20017361376
   PubMedGoogle Scholar
• MulsantBH.PollockBG.Psychopharmacology. In: Blazer DG, Steffans DC, Busse EW, eds.The American Psychiatric Publishing Textbook of Geriatric Psychiatry 3rd ed. Washington, DC: American Psychiatric Publishing;2004387411
   Google Scholar
• KatonaCLE.HunterBN.BrayJ.A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia.Int J Geriatr Psychiatry.1998131001089526179
   PubMed Web of Science ®Google Scholar
• NythAL.GottfriesCG.The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders, a nordic multicentre study.Br J Psychiatry.19901578949011705151
   PubMed Web of Science ®Google Scholar
• NythAL.GottfriesCG.LybyK.et al.A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.Acta Psychiatr Scand.1992861381451529737
   PubMed Web of Science ®Google Scholar
• OlafssonK.JorgensenS.JensenHV.BilleA.ArupP.AndersonJ.Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study.Acta Psychiatr Scand.1992854534561642129
   PubMed Web of Science ®Google Scholar
• TaraganoFE.LyketsosCG.MangoneCA.AHegriRF.Comesana-DiazE.A double-blind, randomized, fixed-dose trial of fluoxetine vs amitriptyline in the treatment of major depression complicating Alzheimer's disease.Psychosomatics.1997382462529136253
   PubMed Web of Science ®Google Scholar
• RooseSP.Considerations for the use of antidepressants in patients with cardiovascular disease.Am Heart J.2000140(4 suppl)S84S88
   Web of Science ®Google Scholar
• KrïshnanKR.DelongM.KraemerH.et al.Comorbidity of depression with other medical diseases in the elderly.Biol Psychiatry.20025255958812361669
   PubMed Web of Science ®Google Scholar
• AndersenG.VestergaardK.LauritzenL.Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram.Stroke.199425109911048202964
   PubMed Web of Science ®Google Scholar
• RobinsonR.SchultzS.CastilloC.Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebocontrolled, double-blind study.Am J Psychiatry.200015735135910698809
   PubMed Web of Science ®Google Scholar
• ArranzFJ.RosS.Effects of comorbidity and polypharmacy on the clinical usefulness of sertraline in elderly depressed patients: an open multicentre study.J Affect Disord.1997462852919547126
   PubMed Web of Science ®Google Scholar
• EvansM.HammondM.WilsonK.LyeM.CopelandJ.Treatment of depression in the elderly: effect of physical illness on response.Int J Geriatr Psychiatry.199712118911949444543
   PubMed Web of Science ®Google Scholar
• GoodnickPJ.HernandezM.Treatment of depression in comorbid medical illness.Expert Opin Pharmacother.200011367138411249471
   PubMedGoogle Scholar
• SolaiLK.MulsantB.PollockBG.Selective serotonin reuptake inhibitors for late-life depression: a comparative review.Drugs Aging.20011835536811392444
   PubMed Web of Science ®Google Scholar
• TraplerB.CohenCI.Use of SSRI in “very old” depressed nursing home residents.Am J Geriatr Psychiatry.1998683899469218
   PubMed Web of Science ®Google Scholar
• MulsantBH.AlexopoulosGS.ReynoldsCF.et al.Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm.Int J Geriatr Psychiatry.20011658559211424167
   PubMed Web of Science ®Google Scholar
• FurlanPM.KalianMJ.Ten HaveT.PollockBG.KatzI.LuckiI.Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers.Am J Geriatr Psychiatry.2001942943811739070
   PubMed Web of Science ®Google Scholar
• NewhousePA.KrishnanKR.DoraiswamyPM.RichterEM.BatzarED.ClaryCM.A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.J Clin Psychiatry.20006155956810982198
   PubMed Web of Science ®Google Scholar
• SchneiderLS.NelsonJC.ClaryCM.et al.An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.Am J Psychiatry.20031601277128512832242
   PubMed Web of Science ®Google Scholar
• RooseSP.SackeimHA.KrishnanKRR.et al.Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial.Am J Psych ia try.200416120502059
   PubMed Web of Science ®Google Scholar
• PollockBG.Adverse reactions of antidepressants in elderly patients.J Clin Psychiatry.199960(suppl 20)S4S8
   PubMed Web of Science ®Google Scholar
• NierenbergAA.AmsterdamJD.Treatment-resistant depression: definition and treatment approaches.J Clin Psychiatry.19905139472112132
   PubMedGoogle Scholar
• ThaseME.RushAJ.Treatment-resistant depression. In: Bloom FE, Kupfer DJ, eds.Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press;199510811098
   Google Scholar
• O'ReardonJP.AmsterdamJD.Treatment-resistant depression: progress and limitations.Psych Ann.199828633640
   Web of Science ®Google Scholar
• KellerMB.ShapiroRW.LavoriPW.WolfeN.Relapse in major depressive disorder: analysis with the life table.Arch Gen Psychiatry.1982399119157103680
   PubMed Web of Science ®Google Scholar
• PaykelES.Epidemiology of refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD, eds.Refractory Depression: Current Strategies and Future Directions. New York, NY: Wiley;1994318
   Google Scholar
• SoueryD.AmsterdamJ.de MontïgnyC.et al.Treatment resistant depression: methodological overview and operational criteria.Eur Neuropsychopharmacol.19999839110082232
   PubMed Web of Science ®Google Scholar
• FagioliniA.KupferDJ.Is treatment-resistant depression a unique subtype of depression?Biol Psychiatry.20035364064812706950
   PubMed Web of Science ®Google Scholar
• RushAJ.FavaM.WïsnïewskïSR.et al.Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design.Control Clin Trial.200425119142
   PubMedGoogle Scholar
• OhayonMM.SchatzbergAF.Prevalence of depressive episodes with psychotic features in the general population.Am J Psychiatry.20021591855186112411219
   PubMed Web of Science ®Google Scholar
• CharneyDS.NelsonJC.Delusional and nondelusional unipolar depression: further evidence for distinct subtypes.Am J Psychiatry.19811383283336110345
   PubMed Web of Science ®Google Scholar
• CoryellW.TsuangMT.Primary unipolar depression and the prognostic importance of delusions.Arch Gen Psychiatry.198239118111847125847
   PubMed Web of Science ®Google Scholar
• ParkerG.RoyK.Hadzi-PavlovîcD.PedicF.Psychotic (delusional) depression: a meta-analysis of physical treatments.J Affect Disord.19922417241347545
   PubMed Web of Science ®Google Scholar
• SpikerDG.WeissJC.DealyRS.et al.The pharmacological treatment of delusional depression.Am J Psychiatry.19851424304363883815
   PubMed Web of Science ®Google Scholar
• DubeS.AndersenSW.SangerTM.HostetlerJ.TohenMF.TollefsonGD.Olanzapine-fluoxetine combination for psychotic major depression. Presented at: 155th Annual Meeting of the American Psychiatric Association; Philadelphia, Pa. 2002 5 18-23
   Google Scholar
• BelanoffJK.RothschildAJ.CassïdyF.et al.An open label trial of C-1073 (mifepristone) for psychotic major depression.Biol Psychiatry.20025238639212242054
   PubMed Web of Science ®Google Scholar
• RothschildAJ.Challenges in the treatment of depression with psychotic features.Biol Psychiatry.20035368069012706954
   PubMed Web of Science ®Google Scholar
• HimmelhochJM.ThaseME.MallingerAG.HouckP.Tranylcypromine versus imipramine in anergic bipolar depression.Am J Psychiatry.19911489109162053632
   PubMed Web of Science ®Google Scholar
• GoodwinFK.JamisonKR.Manic-Depressive Illness. New York, NY: Oxford University Press;1990
   Google Scholar
• ThaseME.SachsGS.Bipolar depression: pharmacotherapy and related therapeutic strategies.Biol Psychiatry.20004855857211018227
   PubMed Web of Science ®Google Scholar
• CalabreseJR.BowdenCL.SachsG.et al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.J Clin Psychiatry.2003641013102414628976
   PubMed Web of Science ®Google Scholar
• TohenM.VietaE.CalabreseJR.et al.Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.Arch Gen Psychiatry.2003601079108814609883
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association Practice guideline for the treatment of patients with bipolar disorder (revision).Am J Psychiatry.2002156350
   Google Scholar
• ThaseME.SachsGS.The challenges of pharmacotherapy of bipolar disorder.Clin Neurosci Res.20022213221
   Google Scholar
• CalabreseJR.BowdenCL.SachsGS.AscherJA.MonaghanE.RuddGD.A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression.J Clin Psychiatry.199960798810084633
   PubMed Web of Science ®Google Scholar
• NemeroffCB.EvansDL.GyulaiL.SachsGS.BowdenCL.GergelIP.Doubleblind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.Am J Psychiatry.200115890691211384898
   PubMed Web of Science ®Google Scholar
• EmslieGJ.HeiligensteinJH.WagnerKD.et al.Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.J Am Acad Child Adolesc Psychiatry.2002411205121512364842
   PubMed Web of Science ®Google Scholar
• KellerM.RyanND.StroberM.et al.Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.J Am Acad Child Adolesc Psychiatry.20014076277211437014
   PubMed Web of Science ®Google Scholar
• UmapathyC.MulsantBH.PollockBG.Bipolar disorder in the elderly.Psychiatr Ann.200030473480
   Web of Science ®Google Scholar
• NunesEV.DeliyannidesD.DonovanS.McGrathPJ.The management of treatment resistance in depressed patients with substance use disorders.Psychiatr Clin North Am.1996193113278827192
   PubMed Web of Science ®Google Scholar
• WorthingtonJ.FavaM.AgustinC.et al.Consumption of alcohol, nicotine, and caffeine among depressed outpatients: relationship with response to treatment.Psychosomatics.1996375185228942202
   PubMed Web of Science ®Google Scholar
• AlpertJE.LagomasinoIT.Psychiatric comorbidity in treatment-resistant depression. In: Amsterdam JD, Hornig M, Nierenberg AA, eds.Treatment-Resistant Mood Disorders. New York, NY: Cambridge University Press;2001430478
   Google Scholar
• O'ReardonJP.AmsterdamJD.Medical disorders and treatment-resistant depression. In: Amsterdam JD, Hornig M, Nierenberg AA, eds.Treatment-Resistant Mood Disorders. New York, NY: Cambridge University Press;2001405429
   Google Scholar
• Frasure-SmithN.LesperanceF.TalajicM.Depression following myocardial infarction: impact on 6-month survival.JAMA.1993270181918258411525
   PubMed Web of Science ®Google Scholar
• AhernDK.GorkinL.AndersonJL.et al.Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).Am J Cardiol.19906659622193497
   PubMed Web of Science ®Google Scholar
• KaufmannMW.FïtzgibbonsJP.SussmanEJ.et al.Relation between myocardial infarction, depression, hostility, and death.Am Heart J.199913854955410467207
   PubMed Web of Science ®Google Scholar
• BushDE.ZiegelsteïnRC.TaybackM.et al.Even minimal symptoms of depression increase mortality risk after acute myocardial infarction.Am J Cardiol.20018833734111545750
   PubMed Web of Science ®Google Scholar
• Frasure-SmithN.LesperanceF.Depression: a cardiac risk factor in search of a treatment.JAMA.20032893171 317312813125
   PubMed Web of Science ®Google Scholar
• GlassmanAH.O'ConnorCM.CalïffRM.et al.Sertraline treatment of major depression in patients with acute MI or unstable angina.JAMA.200228870170912169073
   PubMed Web of Science ®Google Scholar
• GeddesJR.ButlerR.Depressive Disorders in Adults: Clinical Evidence. London, UK: BMJ Publishing Group;2002
   Google Scholar
• SchulbergHC.KatonW.SimonGE.RushAJ.Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines.Arch Gen Psychiatry.199855112111279862556
   PubMed Web of Science ®Google Scholar
• GeddesJR.CarneySM.DaviesC.et al.Relapse prevention with antidepressive drug treatment in depressive disorders: a systematic review.Lancet.200336165366112606176
   PubMed Web of Science ®Google Scholar
• GilaberteI.MontejoAL.de la GandaraJ.et al.Fluoxetine in the prevention of depressive recurrences: a double-blind study.J Clin Psychopharmacol.20012141742411476126
   PubMed Web of Science ®Google Scholar
• KlysnerR.Bent-HansenJ.HansenHL.et al.Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy.Br J Psychiatry.2002181293512091260
   PubMed Web of Science ®Google Scholar
• HochstrasserB.IsaksenPM.KoponenH.et al.Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy.Br J Psychiatry.200117830431011282808
   PubMed Web of Science ®Google Scholar
• LepineJP.GaillardV.BisserbeJC.et al.A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder.Am J Psychiatry.200416183684215121648
   PubMed Web of Science ®Google Scholar
• KellerMB.KocsisJH.ThaseME.et al.Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.JAMA.1998280166516729831997
   PubMed Web of Science ®Google Scholar
• KocsisJH.FriedmanRA.MarkowïtzJC.et al.Maintenance therapy for chronic depression: a controlled clinical trial of desipramine.Arch Gen Psychiatry.1996537697748792753
   PubMed Web of Science ®Google Scholar
• NestlerEJ.GouldE.ManjiH.et al.Preclinical models: status of basic research in depression.Biol Psychiatry.20025250352812361666
   PubMed Web of Science ®Google Scholar
• KraemerHC.LoweKK.KupferDJ.To Your Health: How to Understand What Research Tells Us About Risk. New York, NY: Oxford University Press;2005
   Google Scholar